Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biocompatible Sensor Implant Allows Brain Monitoring Through Development

By HospiMedica International staff writers
Posted on 15 Jan 2025

Advanced electronics have been in development for several decades, resulting in a vast collection of circuit designs. More...

However, most of these transistor and amplifier technologies are incompatible with human physiology. In traditional bioelectronics, complementary transistors are made from different materials to handle the varying polarities of signals. These designs, while functional, are often rigid and cumbersome and present a risk of toxicity when implanted in sensitive areas. Now, researchers have developed a biocompatible sensor implant by embedding transistors in a soft, conformable material to monitor neurological functions through successive stages of a patient’s development.

In a paper published in Nature Communications, scientists from the University of California, Irvine (Irvine, CA, USA) and Columbia University (New York, NY, USA) described their creation of complementary, internal, ion-gated, organic electrochemical transistors. These transistors are more chemically, biologically, and electronically compatible with living tissues compared to rigid, silicon-based technologies. Medical devices based on these transistors can function in delicate parts of the body and adapt to organ structures, even as they grow. The asymmetric design of the transistors allows them to operate using a single, biocompatible material.

By arranging the transistors into a smaller, single-polymer material, the fabrication process is greatly simplified, enabling large-scale production. This innovation opens up possibilities to expand the technology beyond its initial use in neurology to virtually any biopotential process. Additionally, the device can be implanted in a developing animal and can withstand changes in tissue structures as the organism grows—something that rigid, silicon-based implants cannot do. Complementary, internal, ion-gated, organic electrochemical transistors will significantly broaden the scope of bioelectronics, enabling the development of devices that traditionally relied on bulky, non-biocompatible components.

“A transistor is like a simple valve that controls the flow of current. In our transistors, the physical process that controls this modulation is governed by the electrochemical doping and de-doping of the channel,” said first author Duncan Wisniewski, Columbia University Ph.D. “By designing devices with asymmetrical contacts, we can control the doping location in the channel and switch the focus from negative potential to positive potential. This design approach allows us to make a complementary device using a single material.”


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.